// App-Quantinova.ai

2384 : COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Researchers

Presenter

  • Per Ljungman

Principal Investigators

  • Malgorzata Mikulska

  • Gloria Tridello

  • Beatriz Aguado

  • Yves Beguin

  • Rodrigo Martino Bufarull

  • Fabio Ciceri

  • Luca Lpez Corral

  • Claudia Crippa

  • Dries Deeren

  • Rafael F. Duarte

  • Mara Laura Fox

  • Anna Grassi

  • Mara-Jos Jimenez

  • Safiye Koculu

  • Mi Kwon

  • Juan Carlos Vallejo Llamas

  • Jose Luiz Lopez Lorenzo

  • Stephan Mielke

  • Javier Lpez Jimnez

  • Zoraida Mesa Morales

  • Kim H. Orchard

  • Rocio Parody Porras

  • Victoria Potter

  • Mara Surez-Lled

  • Nicolaas Schaap

  • Celestine Simand

  • Luisa Sisinni

  • John A Snowden

  • Daniele Vallisa

  • Ipek Yonalhindilerden

  • Alienor Xhaard

  • Nina Simone Knelange

  • Angel Cedillo

  • Nicolaus Krger

  • Jose Luis Piana Sanchez

  • Jan Styczynski

Medical Centers

  • Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, SWE

  • Hematology Department, Hospital Universitario La Princesa, Madrid, Spain

  • Division of Infectious Diseases, University of Genova, Ospedale Policlinco San Martino, Genova, Italy

  • Paediatric Haematology Oncology,Azienda Ospedaliera Universitaria Integrata,Verona,Italie

  • Hospital Universitario La Paz, Madrid, Spain

  • Department of Neonatology, University of Liege, Liege, Belgium

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • Pathology Unit, San Raffaele H. Scientific Institute, Milano, Italy

  • Hospital Clínico, Servicio de Hematología, Salamanca, Spain

  • Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

  • Algemeen Ziekenhuis Delta,Roeselare,Belgio

  • Hematopoietic Transplantation and Hemato-oncology Section, Institut Català d'Oncologia Hospital Duran i Reynals, Madrid, Spain

  • 7ASST Papa Giovanni XXIII Bergamo Italy

  • Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Research Institute,Badalona,Spain

  • Demiroglu Bilim University ,Istanbul,Turquía

  • Gastroenterology Unit, Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Hospital Donostia, San Sebastian, Spain

  • Servicio de Hematología y Hemoterapia, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

  • Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Stockholms Laen, Sweden

  • Department of Laboratory Medicine, Department of Cell Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska Institute and University Hospital, Stockholm, Sweden

  • Hematology Department, Hospital Universitario La Princesa, Madrid, Spain

  • Hospital Universitario Virgen de las Nieves, Granada, Spain

  • Southampton Univ. Hospitals, Southampton, GBR

  • ICO Duran i Reynals, BARCELONA, Spain

  • Haematological Medicine, Kings College Hospital NHS Foundation Trust, London,

  • Hospital Clinic, Dept. of Hematology, IDIBAPS, Barcelona, Spain, Barcelona, Spain

  • Nijmegen Univ Medical Center, Nijmegen, Netherlands

  • Clinical Hematology, Strasbourg University Hospital, Strasbourg, France

  • Hospital Universitario La Paz, Madrid, Spain

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Hematology Unit and CTMO, G. da Saliceto Hospital, Piacenza, ITA

  • Adult Hematopoietic Stem Cell Transplantation Unit, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey

  • Department of Hematology Transplantation, St-Louis Hospital, APHP, Bone Marrow, Paris, France

  • EBMT Leyden Office, Leyden, The Netherlands,

  • Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular (GETH), Madrid, Spain

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

  • Hematology and hemotherapy department, Hospital Universitari i Politècnic La Fe, Valencia, Spain

  • Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

Locations

  • Spain

  • Italy

  • Belgium

  • Turkey

  • Sweden

  • United Kingdom

  • Netherlands

  • France

  • Germany

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved